In addition to its ability to suppress the expression of E-cadherin, miR-9 also promotes carcinoma invasion and metastasis by targeting the leukemia inhibitory factor receptor (LIFR), leading to the inactivation of prometastatic signals mediated by the Hippo-YAP pathway [97]. Here, LIFR is linked to carcinoma.